Silver Book Fact

A one percent reduction in cancer-related deaths in the U.S. would be worth an estimated $500 billion to society from increased quality of life and increased productivity from longer lives.

Murphy, K and R Topel. The Value of Health and Longevity. J Political Econ. 2006; 114(5): 871-904. https://www.dartmouth.edu/~jskinner/documents/MurphyTopelJPE.pdf

Reference

Title
The Value of Health and Longevity
Publication
J Political Econ
Publication Date
2006
Authors
Murphy, K and R Topel
Volume & Issue
Volume 114, Issue 5
Pages
871-904
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Thousands of potential cancer medicines in development
     
  • Death rates from breast cancer have steadily decreased in women since 1990. This decrease represents progress in both early detection and improved treatment.  
  • According to the Pharmaceutical Research and Manufacturers of America, a cancer medicine in the pipeline would inhibit production of a protein that may interfere with the effectiveness of chemotherapy.  
  • Gains in healthy years of life and social value from cancer R&D
     
  • Between 1990/1991 and 2008, the overall cancer mortality rates decreased by 22.9 percent in men and 15.3 percent in women—around 1,024,400 deaths avoided—primarily due to reductions in tobacco use among…